Devonian Health Advances Thykamine Manufacturing Quality
Quebec, Canada, September 1, 2026 Devonian Health Group Inc. has strengthened the manufacturing and quality-control platform for Thykamine™, its...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Quebec, Canada, September 1, 2026 Devonian Health Group Inc. has strengthened the manufacturing and quality-control platform for Thykamine™, its...
Hong Kong, September 1, 2026 Cornerstone Robotics and Medtronic have entered into a strategic partnership designed to expand global...
Hong Kong, China, May 25, 2026 Cornerstone Robotics (CSR) has announced that its Sentire® Endoscopic Surgical System has officially...
Hong Kong, China – May 25, 2026 Cornerstone Robotics (CSR) announced that its Sentire® Endoscopic Surgical System has officially...
